Upadacitinib trials for Atopic Dermatitis

All Upadacitinib trials · All Atopic Dermatitis trials

Phase breakdown

Recruiting trials studying Upadacitinib for Atopic Dermatitis

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
  NCT06461897 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · 150 locations
• Molecular Signatures in Inflammatory Skin Disease
  NCT03358693 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Replication of the Heads Up Atopic Dermatitis Trial With Registry Data
  NCT06937788 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Upadacitinib for Atopic Dermatitis?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.